NYLIM
ROIV icon

New York Life Investment Management’s Roivant Sciences ROIV Stock Holding History

New York Life Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36,727
Closed -$556K – 840
2025
Q3 		$556K Buy
36,727
+189
+0.5% +$2.34K ﹤0.01% 762
2025
Q2 		$412K Sell
36,538
-1,470
-4% -$15.9K ﹤0.01% 777
2025
Q1 		$384K Sell
38,008
-375
-1% -$4.05K ﹤0.01% 798
2024
Q4 		$454K Buy
+38,383
New +$454K ﹤0.01% 786

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

New York Life Investment Management's ROIV Position: Q4 2025 in Review

New York Life Investment Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 36,727 shares — an estimated $556K sold.

New York Life Investment Management first reported a position in ROIV in Q4 2024 and held it in 4 quarters. The position peaked at $556K in Q3 2025. 398 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • New York Life Investment Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 36,727 Roivant Sciences shares in Q4 2025, an estimated $556K.
  • New York Life Investment Management first reported a position in Roivant Sciences in Q4 2024 and held it in 4 quarters.
  • New York Life Investment Management's Roivant Sciences position peaked at $556K in Q3 2025.
  • 398 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.